DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

People who are of European descent may be more at risk of age-related macular degeneration than those of African or Hispanic ...

In the last 20 years, there have been rapid advances in the treatment options ... patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

WALTHAM, Mass. - Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.7 billion market cap biotech company showing impressive revenue growth of 162% over the last twelve months, today announced that the ...

However, bevacizumab is not currently licensed for neovascular age-related macular degeneration (nAMD). Our study is the first trial-based ... Patients allocated to discontinuous treatment began a new ...

Australia's Therapeutic Goods Administration has approved the use of a new and first treatment for geographic atrophy - a disease which causes severe ...

In this Healio Video Perspective from Retina 2025, Peter K. Kaiser, MD, of Ocular Therapeutix, discusses positive data for ...

Dame Judi Dench has given an update on her failing eyesight due to macular disease, admitting that she can no longer leave ...

[10,46,47] Ranibizumab and dexamethasone IVT implant have recently been approved for treatment of visual impairment due to macular oedema secondary to both BRVO and CRVO. It is therefore relevant ...

The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to ...

Many people who have age-related macular degeneration don't know it. But ignoring this condition can lead to vision loss that can make it hard to perform everyday tasks. Many people who have ...